BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25511681)

  • 21. [Clinicopathologic analysis of 7 cases of primary cutaneous NK/T cell lymphoma, nasal type].
    Zhou DM; Chen G; Zheng XW; Li C; He YZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):772-3. PubMed ID: 22336163
    [No Abstract]   [Full Text] [Related]  

  • 22. [Analytical study of 13 cases of cutaneous lymphoma].
    Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
    Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
    [No Abstract]   [Full Text] [Related]  

  • 23. An acute onset of plaques and tumours on the trunk and limbs of a 52-year-old man.
    Asher RG; Calonje E; Robson A; Scarisbrick J
    Clin Exp Dermatol; 2009 Aug; 34(6):741-2. PubMed ID: 19635117
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathology case of the month. A cheek mass in a young woman. Subcutaneous panniculitis-like T-cell lymphoma.
    Reddy P; Veillon DM; Nordberg ML; Flamholz RB; Cunningham M; Mansour RP; Cotelingam JD
    J La State Med Soc; 2003; 155(5):232-4. PubMed ID: 14748482
    [No Abstract]   [Full Text] [Related]  

  • 25. Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
    Johnson WT; Leeman-Neill RJ; Patel P; Ho J; Grandinetti LM; Jedrych J; Craig FE
    Am J Dermatopathol; 2016 Nov; 38(11):832-837. PubMed ID: 27322928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas.
    Dumont M; Ram-Wolff C; Roelens M; Brice P; Peffault de Latour R; Battistella M; Madelaine I; Delyon J; Herms F; Bouaziz JD; Moins-Teisserenc H; Lebbé C; Bagot M; de Masson A
    Br J Dermatol; 2019 Dec; 181(6):1315-1317. PubMed ID: 31206589
    [No Abstract]   [Full Text] [Related]  

  • 27. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 28. Extracutaneous tumour mass following bexarotene and interferon therapy of primary cutaneous CD30+ large cell lymphoma.
    Kreuter A; Altmeyer P; Gambichler T
    Acta Derm Venereol; 2006; 86(3):274-5. PubMed ID: 16710601
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
    Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
    Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
    Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
    Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous T-cell lymphoma: a review of current therapies and the future therapeutic implications of chemokine biology.
    Momtaz P; Zippin JH
    J Drugs Dermatol; 2009 Dec; 8(12):1142-9. PubMed ID: 20027945
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous intravascular natural killer-cell lymphoma: a rare case and review of the literature.
    Liao JB; Hsieh PP; Hwang YC; Lin SL; Wu CS
    Acta Derm Venereol; 2011 Jun; 91(4):472-3. PubMed ID: 21394417
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    Kannangara AP; Levitan D; Fleischer AB
    J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature.
    James E; Sokhn JG; Gibson JF; Carlson K; Subtil A; Girardi M; Wilson LD; Foss F
    Leuk Lymphoma; 2015 Apr; 56(4):951-7. PubMed ID: 24996443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-grade pleomorphic T cell lymphoma with restricted involvement of skin and bone marrow.
    Gautier MS; Piérard GE; Andrien F; Hermanns JF; Piérard-Franchimont C; Fillet G; Lapière CM
    Dermatology; 1993; 186(4):287-9. PubMed ID: 8513200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Cutaneous Peripheral T-Cell Lymphoma in a Sporotrichoid Pattern: A Case Report.
    Lewis DJ; Vin H; Hinojosa T; Tetzlaff MT; Dabaja BS; Duvic M
    J Cutan Med Surg; 2017; 21(6):568-571. PubMed ID: 28712310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical remission of primary aggressive CD8+ cutaneous T-cell lymphoma after pralatrexate infusion.
    Kerdel FA; Styperek AR; Maini A
    JAMA Dermatol; 2014 Mar; 150(3):320-2. PubMed ID: 24452280
    [No Abstract]   [Full Text] [Related]  

  • 38. Atypical shock and skin lesions revealing lymphoma.
    Fenot M; Lassalle V; Maillard H; De Ybarlucea LR; Celerier P
    Acta Derm Venereol; 2013 Sep; 93(5):592-3. PubMed ID: 23420349
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.
    Theurich S; Schlaak M; Steguweit H; Heukamp LC; Wennhold K; Kurschat P; Rabenhorst A; Hartmann K; Schlösser H; Shimabukuro-Vornhagen A; Holtick U; Hallek M; Stadler R; von Bergwelt-Baildon M
    J Clin Oncol; 2016 Apr; 34(12):e110-6. PubMed ID: 25348001
    [No Abstract]   [Full Text] [Related]  

  • 40. [Granulomatous slack skin with anaplastic large cell lymphoma: report of a case].
    Xie JJ; Zhou ZQ; Wang Y; Li Y; Zhang RY; Ren YB; Chen B; Zhou GY
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):267-8. PubMed ID: 21616005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.